Day 1, Tuesday, March 18th, 2025Tuesday, 18 March 2025 - EST/EDT (Eastern Daylight, GMT-4)

Explore the transformative dynamics shaping healthcare coverage and access in 2025, with a special focus on the most pressing trends and issues that are set to redefine the industry. 

• Gauge the impact of the November 2024 elections on the direction of health policy at the federal level, especially as it relates to the Inflation Reduction Act and Affordable Care Act 

• Gain insights into the evolving regulatory environment, including updates on the Part D benefit redesign and rollout of the Medicare Prescription Payment Plan 

• Assess the continued prevalence of payer and employer models restricting the use of manufacturer-sponsored financial assistance 

• Discuss potential policy solutions and strategies to address the barriers to healthcare access 

In fall 2024, the PAN Foundation conducted national polling that illuminated a sobering statistic: 87% of Medicare beneficiaries had not seen, read or heard anything about the Medicare Part D reforms to take effect January 1, 2025. The PAN Foundation has since led a national education effort to shift that statistic—and subsequently polled people with Medicare again in 2025 to measure the impact of educational outreach.

In this session: 

• Gain access to new research and insights on the current state of awareness among Medicare beneficiaries of the Part D cap and Medicare Prescription Payment Plan—and the role of education in shifting that awareness 

• Learn more about national educational efforts intended to increase awareness, knowledge and ultimately, patients’ ability to make empowered decisions around their healthcare 

• Discuss practical strategies to ensure patients know about these reforms, increase health literacy and provide access to high quality and culturally competent health information 

Diagnosed with Lupus in 2004, Shanelle has dedicated her life to raising awareness, amplifying patient voices and pushing for greater diversity in healthcare. With spoken word and musical performances on global stages like Lincoln Center to the Vatican and advocacy work spanning from Capitol Hill to clinical trial awareness, Shanelle brings a unique perspective to the patient experience. As a member of the Lupus Voices Council and a celebrated artist, Shanelle will share her powerful journey of resilience, creativity and the role of art in patient engagement. 

In this exclusive roundtable, industry leaders will dive deep into how patient access needs are being assessed and the critical role affordability plays in shaping healthcare decisions. With a focus on real-world strategies and emerging trends, explore how data-driven insights are informing policy, operational changes and innovative approaches to patient support.

• Define the latest innovative approaches to delivering best-in-class patient support service
• Identify the approaches that are right for you, your patients and your healthcare providers
• Learn how to evolve your patient support model to stay ahead in a rapidly changing market

The patient services industry is undergoing a massive transformation and now more than ever, stakeholders are revisiting the different operating models to look at their programs from a different lens.

• Uncover the trends in the types of hub models and benchmark on the challenges, benefits and pros/cons of each model type

• Discover best practices in optimizing and integrating your hub model into your business

• Understand how to diversify your portfolio where it makes sense, including potentially offshore

During this session, deep dive into how AI is being used to elevate hub services, tip toeing a fine line between human interaction and automation. Grapple with time frames and level set expectations to think about how to use AI in the way that makes the most sense for your organization. Understand the workarounds surrounding privacy and security, key metrics of success and an analysis of the potential cost savings.

• Analyze the impact of drug pricing on hub operations, including the correlation between drug cost and hub expenses, and strategies for managing those high-cost therapies.

• Benchmark on payer reimbursement challenges and evolving reimbursement models.

• Peek into the future to uncover upcoming industry trends, emerging payment models and best practices to adapt to this changing reimbursement landscape.

During this session, address the hottest questions surrounding hub programs for complex therapies including:

• With the rise in specialty care, what is the current industry standard for hub programs for high cost and high coordination therapies, such as cell and gene therapy?

• What services should be included and excluded in this type of hub?

• What kind of manufacturer support is expected by the patients, providers and payers?